Effectiveness of the Assessment of Burden of Chronic Obstructive Pulmonary Disease (ABC) tool: study protocol of a cluster randomised trial in primary and secondary care

BMC Pulmonary Medicine

Onno CP van Schayck^1,10  Daniel Kotz^1,10  Gerard van Breukelen^1,11  Denise Schuiten²  Richard PN Dekhuijzen³  Sebastiaan Holverda⁸  Philippe L Salomé¹  Guus M Asijee²  Huib AM Kerstjens⁹  Maureen PMH Rutten-van Mölken⁶  Thys van der Molen⁴  Niels H Chavannes⁵  Johannes CCM in ’t Veen⁷  Annerika HM Slok^1,10 

[1] Huisartsenzorg IJsselstein, locatie ’t Steyn, IJsselstein, The Netherlands;PICASSO foundation for COPD, Alkmaar, The Netherlands;Department of Pulmonary Diseases, University Medical Centre Nijmegen, Nijmegen, The Netherlands;Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Centre, Groningen, The Netherlands;Department of Public Health and Primary Care, Leiden University Medical Centre, PO Box 9600, 2300 RC Leiden, The Netherlands;Erasmus University Rotterdam, Institute for Health Policy and Management/Institute for Medical Technology Assessment, PO Box 1738, 3000 DR Rotterdam, The Netherlands;Department of Pulmonology, Sint Franciscus Gasthuis, Rotterdam, The Netherlands;Lung Foundation Netherlands, Amersfoort, The Netherlands;Department of Pulmonary Diseases, University of Groningen, University Medical Centre Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands;Department of Family Medicine, Maastricht University, CAPHRI School for Public Health and Primary Care, PO Box 616, 6200 MD Maastricht, The Netherlands;Department of Methodology & Statistics, Maastricht University, CAPHRI School for Public Health and Primary Care, PO Box 616, 6200 MD Maastricht, The Netherlands

关键词: Patient empowerment;    Pulmonologists;    GPs;    Shared decision making;    Patient reported outcomes;    Quality of life;    Disease burden;    Chronic obstructive pulmonary disease;   

Others  :  1109554
DOI  :  10.1186/1471-2466-14-131

 received in 2014-07-09, accepted in 2014-07-31,  发布年份 2014

【 摘 要 】

Background

Chronic Obstructive Pulmonary Disease (COPD) is a growing worldwide problem that imposes a great burden on the daily life of patients. Since there is no cure, the goal of treating COPD is to maintain or improve quality of life. We have developed a new tool, the Assessment of Burden of COPD (ABC) tool, to assess and visualize the integrated health status of patients with COPD, and to provide patients and healthcare providers with a treatment algorithm. This tool may be used during consultations to monitor the burden of COPD and to adjust treatment if necessary. The aim of the current study is to analyse the effectiveness of the ABC tool compared with usual care on health related quality of life among COPD patients over a period of 18 months.

Methods/Design

A cluster randomised controlled trial will be conducted in COPD patients in both primary and secondary care throughout the Netherlands. An intervention group, receiving care based on the ABC tool, will be compared with a control group receiving usual care. The primary outcome will be the change in score on a disease-specific-quality-of-life questionnaire, the Saint George Respiratory Questionnaire. Secondary outcomes will be a different questionnaire (the COPD Assessment Test), lung function and number of exacerbations. During the 18 months follow-up, seven measurements will be conducted, including a baseline and final measurement. Patients will receive questionnaires to be completed at home. Additional data, such as number of exacerbations, will be recorded by the patients’ healthcare providers. A total of 360 patients will be recruited by 40 general practitioners and 20 pulmonologists. Additionally, a process evaluation will be performed among patients and healthcare providers.

Discussion

The new ABC tool complies with the 2014 Global Initiative for Chronic Obstructive Lung Disease guidelines, which describe the necessity to classify patients on both their airway obstruction and a comprehensive symptom assessment. It has been developed to classify patients, but also to provide visual insight into the burden of COPD and to provide treatment advice.

Trial registration

Netherlands Trial Register, NTR3788.

【 授权许可】

   
2014 Slok et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD, Rodriguez-Roisin R: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013, 187:347-365.
• [2]Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Barker-Collo S, Bartels DH, Bell ML, Benjamin EJ, Bennett D, Bhalla K, Bikbov B, Bin Abdulhak A, Birbeck G, Blyth F, Bolliger I, Boufous S, Bucello C, Burch M, et al.: Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2095-2128.
• [3]Mathers CD, Loncar D: Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006, 3:e442.
• [4]Tsiligianni I, Kocks J, Tzanakis N, Siafakas N, van der Molen T: Factors that influence disease-specific quality of life or health status in patients with COPD: a review and meta-analysis of Pearson correlations. Prim Care Respir J 2011, 20:257-268.
• [5]Santo Tomas LH, Varkey B: Improving health-related quality of life in chronic obstructive pulmonary disease. Curr Opin Pulm Med 2004, 10:120-127.
• [6]Domingo-Salvany A, Lamarca R, Ferrer M, Garcia-Aymerich J, Alonso J, Felez M, Khalaf A, Marrades RM, Monso E, Serra-Batlles J, Anto JM: Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002, 166:680-685.
• [7]Antonelli-Incalzi R, Pedone C, Scarlata S, Battaglia S, Scichilone N, Forestiere F, Bellia V: Correlates of mortality in elderly COPD patients: focus on health-related quality of life. Respirology 2009, 14:98-104.
• [8]Fan VS, Curtis JR, Tu SP, McDonell MB, Fihn SD: Using quality of life to predict hospitalization and mortality in patients with obstructive lung diseases. Chest 2002, 122:429-436.
• [9]Slok AHM, Veen JCCM i ’t, Chavannes NH, van der Molen T, Rutten-van Mölken MPMH, Kerstjens HAM, Salomé PL, Holverda S, Dekhuijzen R, Schuiten D, Asijee GM, van Schayck OCP: Development of the Assessment of Burden of COPD (ABC) tool an integrated tool to measure the burden of COPD. NPJ Prim Care Respir MedPublished online, 10 July 2014
• [10]Elwyn G, Frosch D, Thomson R, Joseph-Williams N, Lloyd A, Kinnersley P, Cording E, Tomson D, Dodd C, Rollnick S, Edwards A, Barry M: Shared decision making: a model for clinical practice. J Gen Intern Med 2012, 27:1361-1367.
• [11]Van der Molen T, Willemse BW, Schokker S, Ten Hacken NH, Postma DS, Juniper EF: Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes 2003, 1:13.
• [12]Jones PW, Quirk FH, Baveystock CM: The St George’s respiratory questionnaire. Respir Med 1991, 85:25-31.
• [13]Makoul G, Clayman ML: An integrative model of shared decision making in medical encounters. Patient Educ Couns 2006, 60:301-312.
• [14]Kocks J, de Jong C, Berger MY, Kerstjens HAM, van der Molen T: Putting health status guided COPD management to the test: protocol of the MARCH study. BMC Pulm Med 2013, 13:1-9.
• [15]Smeele IJM, Van Weel C, Van Schayck CP, Van der Molen T, Thoonen B, Schermer T, Sachs APE, Muris JWM, Chavannes NH, Kolnaar BGM, Grol MH, Geijer RMM: NHG Standaard COPD. Huisarts Wet 2007, 50:362-379.
• [16]Dekhuijzen PNR, Broeders MEAC, Grol MH, Tuut MK: Richtlijn Diagnostiek en behandeling van COPD. Utrecht: Kwaliteitsinstituut voor de Gezondheidszorg CBO; 2010.
• [17]From the global strategy for diagnosis, management and prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2014 http://www.goldcopd.org/ webcite
• [18]Long Alliantie Nederland: Zorgstandaard COPD [Care Standard COPD]. Amersfoort: Long Alliantie Nederland; 2010.
• [19]Jones PW: St. George’s respiratory questionnaire: MCID. Copd 2005, 2:75-79.
• [20]Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N: Development and first validation of the COPD assessment test. Eur Respir J 2009, 34:648-654.
• [21]Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia X: Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5 L). Qual Life Res 2011, 20:1727-1736.
• [22]van Hout B, Janssen MF, Feng YS, Kohlmann T, Busschbach J, Golicki D, Lloyd A, Scalone L, Kind P, Pickard AS: Interim scoring for the EQ-5D-5 L: mapping the EQ-5D-5 L to EQ-5D-3 L value sets. Value Health 2012, 15:708-715.
• [23]Glasgow RE, Wagner EH, Schaefer J, Mahoney LD, Reid RJ, Greene SM: Development and validation of the Patient Assessment of Chronic Illness Care (PACIC). Med Care 2005, 43:436-444.
• [24]Tashkin D, Kesten S: Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responses. Chest 2003, 123:1441-1449.
• [25]Casaburi R, Mahler DA, Jones PW, Wanner A, San PG, ZuWallack RL, Menjoge SS, Serby CW, Witek T Jr: A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J 2002, 19:217-224.
• [26]Adams G, Gulliford MC, Ukoumunne OC, Eldridge S, Chinn S, Campbell MJ: Patterns of intra-cluster correlation from primary care research to inform study design and analysis. J Clin Epidemiol 2004, 57:785-794.
• [27]Eldridge SM, Ashby D, Feder GS, Rudnicka AR, Ukoumunne OC: Lessons for cluster randomized trials in the twenty-first century: a systematic review of trials in primary care. Clin Trials 2004, 1:80-90.
• [28]Van Breukelen GJ, Candel MJ: Efficient design of cluster randomized and multicentre trials with unknown intraclass correlation. Stat Methods Med Res 2011. Epub ahead of print
• [29]van Breukelen GJ, Candel MJ: Calculating sample sizes for cluster randomized trials: we can keep it simple and efficient! J Clin Epidemiol 2012, 65:1212-1218.
• [30]Candel MJ, Van Breukelen GJ: Sample size adjustments for varying cluster sizes in cluster randomized trials with binary outcomes analyzed with second-order PQL mixed logistic regression. Stat Med 2010, 29:1488-1501.
• [31]Bodnera TE: What improves with increased missing data imputations? Struct Equ Model 2008, 15:651-675.
• [32]Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA: Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999, 54:581-586.
• [33]Hurst JR, Vestbo J, Anzueto A, Locantore N, Mullerova H, Tal-Singer R, Miller B, Lomas DA, Agusti A, Macnee W, Calverley P, Rennard S, Wouters EF, Wedzicha JA: Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010, 363:1128-1138.
• [34]Cazzola M, MacNee W, Martinez FJ, Rabe KF, Franciosi LG, Barnes PJ, Brusasco V, Burge PS, Calverley PM, Celli BR, Jones PW, Mahler DA, Make B, Miravitlles M, Page CP, Palange P, Parr D, Pistolesi M, Rennard SI, Rutten-van Molken MP, Stockley R, Sullivan SD, Wedzicha JA, Wouters EF: Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J 2008, 31:416-469.